ELISAによる自己抗体の測定
the ELISA has been further developed and widely used in medical and research laboratories for the assessment of autoantibodies as well as for commercial applications. (Heliyon. 2020 Jan; 6(1): e03270. Published online 2020 Jan 18. doi: 10.1016/j.heliyon.2020.e03270 PMCID: PMC6971389 PMID: 31993528 Autoantibody testing by enzyme-linked immunosorbent assay-a case in which the solid phase decides on success and failure)
- Autoantibody testing by enzyme-linked immunosorbent assay-a case in which the solid phase decides on success and failure Heliyon. 2020 Jan; 6(1): e03270. Published online 2020 Jan 18. doi: 10.1016/j.heliyon.2020.e03270 PMCID: PMC6971389 PMID: 31993528
アミロイドタンパク質・その他の脳タンパク質に対する自己抗体の測定論文
- Theranostics . 2022 Mar 28;12(7):3045-3056. doi: 10.7150/thno.72126. eCollection 2022. Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases
- Ann Neurol . 2001 Jun;49(6):808-10. doi: 10.1002/ana.1061. Autoantibodies to amyloid-beta and Alzheimer’s disease There were detectable but very low levels of anti-amyloid-beta antibodies in just over 50% of all samples and modest levels in under 5% of all samples.